Live
Clinical OMICsMuscle Quality and Fat Distribution Predict Mortality Risk Better than BMIEndpoints NewsPfizer's Albert Bourla says he has no mega-merger plansClinical OMICsGenotype-Guided Antidepressants Could Have Long-Term BenefitsModernaBoston biotech firms back new effort to preserve U.S. edge in life sciences - The Business JournalsRevvityRevvity Outperforms in Q1 2026 Driven by Pharma Rebound and Strategic Portfolio Shifts - Lab ManagerEndpoints NewsBioNTech to scale down manufacturing, over 1,800 jobs on the lineEndpoints NewsParsley Health goes in-network nationwideRevvityWhy Is Revvity (RVTY) Stock Rocketing Higher Today - TradingViewPfizerPfizer beats estimates but investors cautious - The Pharma LetterBioPharma DiveViridian data lift prospects for thyroid eye disease drugFierceBiotechOlympus, EndoRobotics in distribution pact for robot-assisted endoscopic techBioWorldUCB onboards more autoimmune TCEs with $2.2B Candid buy
This story is not available in the archive.